40.4 LOW-DOSE RISPERIDONE TREATMENT IN ADOLESCENCE PREVENTS THE DEVELOPMENT OF NEUROINFLAMMATION IN THE MATERNAL IMMUNE ACTIVATION MODEL. (1st April 2018)